Re­lief for joint pain and os­teoarthri­tis

The Star Malaysia - Star2 - - STAR SPECIAL -

nEW clin­i­cal trial data pub­lished re­cently in The Jour­nal of Rheuma­tol­ogy showed that Flexiseq gel was ef­fec­tive in manag­ing the pain as­so­ci­ated with os­teoarthri­tis (OA) and was again found to have a much stronger safety pro­file than other treat­ments.

This is the lat­est high-pro­file pub­li­ca­tion af­ter it won the Ger­man Phar­macy In­dus­try award for in­no­va­tion in Jan­uary this year.

Dr Matthias Rother, the pub­li­ca­tion’s lead au­thor, says, “This is an im­por­tant study that con­firms the safety and ef­fi­cacy of Flexiseq for treat­ment of the chronic pain and stiff­ness that trou­ble many pa­tients with OA.

“The ef­fect seen is com­pa­ra­ble to a com­par­a­tive study us­ing the same de­sign, which demon­strated that Flexiseq has equiv­a­lent ef­fi­cacy to the widely used oral NSAID, cele­coxib.”

The find­ings of­fer hope to OA pa­tients, par­tic­u­larly those at risk from the com­mon gas­troin­testi­nal and car­dio­vas­cu­lar side ef­fects as­so­ci­ated with NSAIDs, such as cele­coxib and di­clofenac (which has been the sub­ject of fur­ther health warn­ings from the EMA in July).

Prof Con­aghan, co-au­thor of the paper, says that OA is a wide­spread and chronic dis­ease that causes pain and loss of func­tion, which ad­versely af­fects pa­tients’ lives.

“Many shouldn’t take or can’t tol­er­ate cur­rent oral anal­gesics be­cause of side ef­fects. This study pro­vides fur­ther in­sight into the ef­fi­cacy of this treat­ment that has demon­strated ex­cel­lent safety and tol­er­a­bil­ity. These stud­ies are among sev­eral which con­sis­tently demon­strate the benefits of this drug-free gel.”

Far­ma­sia Sdn Bhd, the distrib­u­tors of Flexiseq in Malaysia, re­cently held a talk for med­i­cal prac­ti­tion­ers given by Dr Matthias. Dr Matthias was happy with the re­sults in some pa­tients af­ter us­ing Flexiseq.

“One pa­tient has been us­ing Flexiseq for one year and she now no longer re­quires oral painkillers. At age 70, this truly is a huge ben­e­fit for her,” he says.

An­other pa­tient who has been us­ing Flexiseq for her knee pain says she is now able to do so many things than be­fore, like kneel­ing and climb­ing steps with ease. She had tried var­i­ous pills and sup­ple­ments but was not able to get ad­e­quate pain re­lief. She now main­tains a once-a-day ap­pli­ca­tion.

In Malaysia, thou­sands of pa­tients have used Flexiseq, gain­ing a new lease of mo­bil­ity and free­dom from pain.

Awarded “In­no­va­tion of 2013” in Ger­many by the Fed­eral As­so­ci­a­tion of Ger­man Phar­ma­cists, Flexiseq is en­gi­neered to treat OA via a phys­i­cal mode of ac­tion.

It em­ploys Se­ques­some Tech­nol­ogy, an im­por­tant re­in­force­ment of the ef­fi­cacy and safety pro­file of Flexiseq.

There is great in­ter­est from the med­i­cal com­mu­nity and huge de­mand from pa­tients, with many re­gard­ing it as a “wonder gel”.

Flexiseq is avail­able in Ger­many, Aus­tria, Ire­land and Malaysia.

About Se­ques­some Tech­nol­ogy

Se­ques­some Tech­nol­ogy utilises nanos­truc­tures called Se­ques­some vesi­cles that cross the skin bar­rier af­ter top­i­cal ap­pli­ca­tion and mi­grate through var­i­ous tis­sues to reach the tar­get joint. Once in­side, Se­ques­some vesi­cles ac­cu­mu­late on the dam­aged car­ti­lage form­ing a lu­bri­cat­ing layer.

This tar­geted, phys­i­cal mode of ac­tion means there are no drug-to­drug in­ter­ac­tions as it is not a drug and can be used safely by pa­tients tak­ing a va­ri­ety of med­i­ca­tions for other con­di­tions.

Flexiseq is a wel­come op­tion for pa­tients con­sid­ered “at risk” from the com­mon side ef­fects as­so­ci­ated with NSAIDs, for ex­am­ple those with high blood pres­sure and/or gas­tric dis­or­ders. With this, pa­tients can con­tinue to main­tain their pain re­lief by us­ing Flexiseq on a longterm ba­sis and ad­just their ap­pli­ca­tion regime to suit their in­di­vid­ual re­quire­ments by re­duc­ing the fre­quency of ap­pli­ca­tion from the ini­tial twice-a-day regime.

Con­sult your doc­tor on how Flexiseq can be in­cor­po­rated into your OA joint pain treat­ment and main­te­nance regime.

For de­tails, visit www.flexiseq. or call 03-6203 2334.

In Malaysia, thou­sands of pa­tients have used Flexiseq, gain­ing a new lease of mo­bil­ity and free­dom from pain.

Newspapers in English

Newspapers from Malaysia

© PressReader. All rights reserved.